Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > (2R,3S)-N-Benzoyl-3-phenylisoserine

(2R,3S)-N-Benzoyl-3-phenylisoserine

(2R,3S)-N-Benzoyl-3-phenylisoserine structure

(2R,3S)-N-Benzoyl-3-phenylisoserine 

structure
  • CAS No:

    132201-33-3

  • Formula:

    C16H15NO4

  • Chemical Name:

    (2R,3S)-N-Benzoyl-3-phenylisoserine

  • Synonyms:

    Benzenepropanoic acid,β-(benzoylamino)-α-hydroxy-,(αR,βS)-;Benzenepropanoic acid,β-(benzoylamino)-α-hydroxy-,[R-(R*,S*)]-;(αR,βS)-β-(Benzoylamino)-α-hydroxybenzenepropanoic acid;N-Benzoyl-(2R,3S)-3-phenylisoserine;(2R,3S)-N-Benzoyl-3-phenylisoserine;(2R,3S)-3-(Benzoylamino)-2-hydroxy-3-phenylpropionic acid

  • Categories:

    Biochemical Engineering  >  Amino Acids and Derivatives

Description

N-Benzoyl-(2R,3S)-3-phenylisoserine is a Taxol C-13 Side Chain and crucial for the strong antitumor activity of Taxol[1].

(2R,3S)-N-Benzoyl-3-phenylisoserine Basic Attributes

285.29

285.29

1806241-263-5

D998Q2WJCM

DTXSID10157433

Characteristics

86.6

1.7

white powder

1.316g/cm3

166-168 °C @ Solvent: Chloroform

580.7°C at 760 mmHg

305ºC

1.625

2.51E-14mmHg at 25°C

Safety Information

NONH for all modes of transport

3

36/37/38

26-36

Xi

P261-P305 + P351 + P338

H315-H319-H335

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

(2R,3S)-N-Benzoyl-3-phenylisoserine Use and Manufacturing

Methods of Manufacturing

A mixture of N-benzoylphenylimine (0.30 mmol), rhodium acetate (0.006 mmol), silver hexafluorophosphate (0.03 mmol) molecular sieve (300 mg) was dissolved in 1.5 mL of LDCM (dichloromethane) solvent.The mixture solution A was prepared and stirred at 25 C for 5 minutes.Further, tert-butyl diazoacetate (0.33 mmol) was dissolved in 1.0 mL of LDCM (dichloromethane) solvent.Formulated as solution B. Solution B was added to the mixed solution A by a syringe pump at 25 C for 1 hour, and stirred for half an hour. Then, trifluoroacetic acid (0.90 mmol) was added to the obtained reaction.Continue to stir for hours. The reaction mixture is purified by flash column chromatography to give a pure product.Its structure is represented by the formula (1) and is N-benzoyl-(2R, 3S)-3-phenylisoserine.The yield was 85% and the dr value was equal to 92:8. A schematic of 1H NMR of the product is shown in Figure 23, and a 13C NMR scheme is shown in Figure 24.Synthesis of N-Benzoyl-(2R, 3S)-3-phenylisoseryl-CoA To a solution of

Uses

(2R,3S)-N-Benzoyl-3-phenylisoserine is an intermediate in the preparation of potent anticancer drug Paclitaxel (P132500) used to study the location of the binding sites. (2R,3S)-N-Benzoyl-3-phenylisoserine shows cytotoxic, antiviral andimmunomodulatory activity.

Computed Properties

Molecular Weight:285.29
XLogP3:1.7
Hydrogen Bond Donor Count:3
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:5
Exact Mass:285.10010796
Monoisotopic Mass:285.10010796
Topological Polar Surface Area:86.6
Heavy Atom Count:21
Complexity:359
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.